Skip to content

Corporate Governance Guidelines

 

The Board of Directors (the “Board”) of Esperion Therapeutics, Inc. (the “Company”) has adopted the corporate governance guidelines set forth below to assist and guide the Board in the exercise of its responsibilities.  These guidelines should be interpreted in accordance with any requirements imposed by applicable federal or state law or regulation, the NASDAQ Stock Market LLC and the Company’s certificate of incorporation, as amended, restated or otherwise modified from time to time (the “Certificate of Incorporation”) and the Company’s bylaws, as amended, restated or otherwise modified from time to time (the “Bylaws”).  The Board may review and amend these guidelines from time to time.

Adopted June 5, 2013, subject to effectiveness of the Company’s Registration Statement on Form S-1.

  • Member
  • Chair
  • Financial Expert
  • Independent Director